Leo Pharma
Board
2 directors, 1 auditor, no change since June 2026Deed of 09-06-2026Reappointment: DELOITTE Bedrijfsrevisoren (statutory auditor)Permanent representative: Pieter-Jan Jean-Baptiste E Van Durme · General meeting of 30-04-2026
Director
current term since 31-03-2022
term until 31-05-2028
listed in the 2025 annual accounts, filed on 06-05-2026
Director
since 27-01-2025
term until 02-06-2031
listed in the 2025 annual accounts, filed on 06-05-2026
Statutory auditor, permanent representative Pieter-Jan Jean-Baptiste E Van Durme
appointed by deed of 03-01-2018
3-year term from 2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Bijgevolg zal de raad van bestuur van de Vennootschap met ingang van 31 januari 2024 om middernacht samengesteld zijn uit twee bestuurders…”deed of 06-02-2024
Mandates through the years
22 names, the dashed line is todayHilda De Swaef
Director
Director
Dilay Kücükkose
Director
Director
Deloitte Bedrijfsrevisoren
Statutory auditor
Statutory auditor
Anders Krüger
Director
Director
Jannie Holm
Director
Director
Michael Grue
Director
Director
Anders Kronborg
Director
Director
Kim Kjøller
Director
Director
De Swaef
Day-to-day manager
Day-to-day manager
Aabo GITTE
Director
Director
PricewaterhouseCoopers, Bedrijfsrevisoren
Statutory auditor
Statutory auditor
Kristian Merser
Director
Director
Hilde De Swaef
Director
Director
Lars Enghave Minor
Director
Director
Lars Olsen
Director
Director
Bo Olesen
Director
Director
Tore Waeborg
Managing director
Managing director
BDO Bedrijfsrevisoren
Statutory auditor
Statutory auditor
Hilde De Swaet
Director (executive)
Director (executive)
Ger Schoor
Director
Director
Ernst Lunding
Director
Director
BoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
- Hilda De Swaef
- Director, appointed by deed of 03-07-2012, still in office
- Managing director, appointed by deed of 03-07-2012, last mentioned in 2012
- Dilay Kücükkose
- Director, since before 31-12-2024
- Deloitte Bedrijfsrevisoren
- Statutory auditor, appointed by deed of 03-01-2018, still in office
- Anders Krüger
- Director, from before 31-12-2023 to 11-02-2025
- Jannie Holm
- Director, from before 31-12-2021 to 06-02-2024
- Michael Grue
- Director, appointed by deed of 03-08-2021, until 30-03-2022
- Catherine Thérése Jeanne MAZZACCO
- Director, from 01-10-2019 to 05-01-2022
- Anders Kronborg
- Director, appointed by deed of 20-05-2016, until 03-08-2021
- Kim Kjøller
- Director, appointed by deed of 28-09-2016, until 03-08-2021
- De Swaef
- Director, until 01-04-2016
- Day-to-day manager, appointed by deed of 29-09-2020, last mentioned in 2020
- Aabo GITTE
- Director, appointed by deed of 04-02-2008, until 31-10-2019
- PricewaterhouseCoopers, Bedrijfsrevisoren
- Statutory auditor, appointed by deed of 08-02-2011, until 01-11-2017
- Kristian Merser
- Director, appointed by deed of 20-05-2016, until 01-09-2016
- Hilde De Swaef
- Director, until 01-04-2016
- Lars Enghave Minor
- Director, appointed by deed of 03-07-2012, until 01-04-2016
- Lars Olsen
- Director, appointed by deed of 06-05-2010, until 01-04-2016
- Bo Olesen
- Director, from before 04-02-2008 to 01-03-2010
- Director, until 01-07-2012
- Tore Waeborg
- Director, appointed by deed of 04-02-2008, until 01-07-2012
- Managing director, appointed by deed of 06-05-2010, until 01-07-2012
- BDO Bedrijfsrevisoren
- Statutory auditor, appointed by deed of 30-12-2008, until 27-09-2010
- Hilde De Swaet
- Director (executive), appointed by deed of 06-05-2010, last mentioned in 2010
- Ger Schoor
- Director, from before 04-02-2008 to 01-03-2010
- Ernst Lunding
- Director, until 01-01-2008
- Director, from before 04-02-2008, no longer listed in the 2025 annual accounts
Control
consolidates
This company
Leo Pharma
Equity €9.9m
Profit €615,360 in 2025
Capital
- Capital
- €272,682.85
- Shares
- 55,992
- Contribution per share
- €4.87
- Equity per share
- €177 in 2025
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- LEO Pharma A/S
- LEO PHARMACEUTICAL PRODUCTS
Source: parent in its own accounts
Articles of association
deed of 25-11-2020 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Kunnen voorzitter en één of meer ondervoorzitters aanstellen, 6 jaar”“Vacature, overblijvende bestuurders of leden kunnen voorlopig voorzien”“Andersluidend besluit algemene vergadering, bestuurders of leden raad van toezicht”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- 31 May